We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Cell-free nucleic acids in cancer patients' blood
- Serum/plasma DNA vs. tumor tissue DNA
- Circulating DNA & nucleosides in breast tumors
- LOCH frequency on cell-free DNA in the serum
- Monitoring of the efficacy of systemic therapies
- Circulating DNA in ovarian cancer patients
- Circulating microns (mires) as biomarkers
- Circulating mires in breast cancer
- Circulating mires in ovarian cancer
- Circulating mires in lung cancer (NASAL)
- Cell-free DNA as an indicator of disease
- Tumor cell circulation and cancer dormancy
- CATCH & the microenvironment of metastasis sites
- CATCH enrichment methods
- CTC/DTC identification methods
- Detection of circulating tumor cells by EPISPOT
- Circulating free DNA & CATCH in prostate cancer (1)
- Circulating free DNA & CATCH in prostate cancer (2)
- Detection of DTC in bone marrow
- Circulating free DNA as potential DTC biomarker
- Molecular characterization of single CATCH
- Genetic analysis of single CATCH in CRC patients
- KRAS mutation analysis on plasma DNA
- Genomic profiling of a single CATCH by CGH
- Conclusions
- Circulating nucleic acids in cancer patients
- Cell-free DNA induces oncogenic transformation
- Cell-free DNA as bio-markers - review
Topics Covered
- Circulating Nucleic Acids
- Advantages of Serum/Plasma DNA vs. Tumor Tissue DNA
- Circulating DNA in patients with benign disease and malignant tumors
- Circulating microRNAs in cancer patients
- Associations between Circulating Tumor Cells and cell-free tumor DNA in cancer patients
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pantel, K. (2012, September 27). Circulating nucleic acids as biomarkers in cancer patients [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 5, 2024, from https://doi.org/10.69645/CPUY7210.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Klaus Pantel has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.